The Phase 1, Open-label, PET Trial Designed to Investigate the Effect of AZD2389 on FAP Occupancy in the Liver in Participants With Advanced Liver Fibrosis.
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to AstraZeneca
Related studies linked through entity extraction aliases.
A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE2
PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease
- Status
- RECRUITING
- Phase
- PHASE2
A Multicenter Observational Study to Understand the Clinical Characteristics, Treatment Patterns and Access to Novel Therapies of Patients With Diffuse Large B-Cell Lymphoma in the MEA Region
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
A Study of Inhaled AZD8630 in Adolescents With Asthma
- Status
- COMPLETED
- Phase
- PHASE1
A Study of AZD2962, an IRAK4 Inhibitor (IRAK4 [a Body Protein] Blocker), in Participants With Haematologic Neoplasms (Blood Cancers)
- Status
- RECRUITING
- Phase
- PHASE1
A Master Protocol Study to Investigate Biomarker-guided Novel Anticancer Agent(s) as Monotherapy or Combination Therapy in Participants With Advanced/Recurrent Ovarian Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
A Study of Osimertinib-based Adaptive Treatment Guided by ctDNA EGFRm+ Monitoring in NSCLC
- Status
- RECRUITING
- Phase
- PHASE2
Aggressive Disease Treatment Patterns and CtDNA HRR evaluatiON in High-volume metastatiC hORmone-sensitive Prostate Cancer in Russian FeDeration
- Status
- RECRUITING
- Phase
- N/A
Anifrolumab Pregnancy Study
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
- Status
- RECRUITING
- Phase
- PHASE3
An Observational Study of Molecular profIling of Advanced and aggRessive ENdometrial Cancer and 1-st Line Treatment Approaches in Russian Federation
- Status
- RECRUITING
- Phase
- N/A
TReatment Approaches and bIomarkers preValence in bladdEr Cancer in RuSsian Federation
- Status
- RECRUITING
- Phase
- N/A
Predictors of Health-Related QOL in Adults With CLL or Small Lymphocytic Lymphoma
- Status
- RECRUITING
- Phase
- N/A
A Study to Evaluate Acalabrutinib, in Combination With the R-CHOP Standard of Care, for Previously Untreated Mantle Cell Lymphoma in Spain
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort
- Status
- RECRUITING
- Phase
- PHASE1
Phase 2 Study of Disease Risk Mutation-Guided Finite Acalabrutinib+Venetoclax for Relapsed CLL Post-1L Finite cBTKi+BCL2i ± Obinutuzumab
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Real World Study of Effectiveness of Sunitinib or Sorafenib to Chinese Unresectable Locally Advanced or Metastatic PRCC
- Status
- RECRUITING
- Phase
- N/A
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
- Status
- RECRUITING
- Phase
- PHASE3
This is a Multi-centre, Multi-drug, Platform Study in Chinese Participants Living With Obesity / Overweight
- Status
- RECRUITING
- Phase
- PHASE2